MétaCan
Menu
Back to cohort

Regulatory Filing Strategies Adopted by Generic Companies

2011· book-chapter· en· W4410785287 on OpenAlexaboutno aff

Bibliographic record

Venuenot available
Typebook-chapter
Languageen
FieldBusiness, Management and Accounting
TopicBusiness Strategy and Innovation
Canadian institutionsnot available
Fundersnot available
KeywordsBusiness

Abstract

fetched live from OpenAlex

Abstract This chapter outlines regulatory filing strategies used by generic pharmaceutical companies in Australia, Canada, China, India, Japan, Germany, Italy, the Netherlands, and the United Kingdom to obtain approval for their products. It explains that in Australia the innovator applies for the inclusion of its patent portfolio on the Australian Register of Therapeutic Goods (ARTG). In Canada, securing a notice of compliance (NOC) first offers a commercial advantage, while in China, early filing with the State Food and Drug Administration (SFDA) is advised due to the lengthy approval process. The chapter details how Japan’s process involves legal opinions of non-infringement, potential MMA approval delays by the Ministry of Health, Labour and Welfare (MHLW), and negotiation requirements if intellectual property issues arise. It discusses harmonised EU and EEC rules followed by Germany, the Netherlands, and the United Kingdom, and Italy’s simplified AIC procedure under Art 10 of Legislative Decree 219/2006.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Theoretical or conceptual · Consensus signal: none
GenreCandidate signal: Other · Consensus signal: Other
Teacher disagreement score0.847
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.002
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0060.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.042
GPT teacher head0.205
Teacher spread0.163 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designTheoretical or conceptual
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2011
Admission routes1
Has abstractyes

Explore more

Same topicBusiness Strategy and InnovationFrench-language works237,207